nodes	percent_of_prediction	percent_of_DWPC	metapath
Enprofylline—ADORA1—Circadian rythm related genes—SERPINE1—metabolic syndrome X	0.00432	0.00432	CbGpPWpGaD
Enprofylline—ADORA2A—Circadian rythm related genes—LEP—metabolic syndrome X	0.00425	0.00425	CbGpPWpGaD
Enprofylline—ADORA2B—GPCR ligand binding—CCL5—metabolic syndrome X	0.00422	0.00422	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling by GPCR—MTNR1B—metabolic syndrome X	0.004	0.004	CbGpPWpGaD
Enprofylline—PDE4A—GPCR downstream signaling—MTNR1B—metabolic syndrome X	0.004	0.004	CbGpPWpGaD
Enprofylline—ADORA2A—GPCR ligand binding—HTR2C—metabolic syndrome X	0.00398	0.00398	CbGpPWpGaD
Enprofylline—ADORA1—Class A/1 (Rhodopsin-like receptors)—AGT—metabolic syndrome X	0.00394	0.00394	CbGpPWpGaD
Enprofylline—ADORA2B—Class A/1 (Rhodopsin-like receptors)—CCL2—metabolic syndrome X	0.00382	0.00382	CbGpPWpGaD
Enprofylline—ADORA2A—GPCR ligand binding—GHRL—metabolic syndrome X	0.00378	0.00378	CbGpPWpGaD
Enprofylline—ADORA1—GPCR downstream signaling—MTNR1B—metabolic syndrome X	0.00374	0.00374	CbGpPWpGaD
Enprofylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—IRS1—metabolic syndrome X	0.00372	0.00372	CbGpPWpGaD
Enprofylline—ADORA2A—Circadian rythm related genes—PPARG—metabolic syndrome X	0.0037	0.0037	CbGpPWpGaD
Enprofylline—PDE4B—GPCR downstream signaling—MTNR1B—metabolic syndrome X	0.0037	0.0037	CbGpPWpGaD
Enprofylline—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CCL5—metabolic syndrome X	0.00364	0.00364	CbGpPWpGaD
Enprofylline—PDE4A—Signaling by GPCR—MTNR1B—metabolic syndrome X	0.00363	0.00363	CbGpPWpGaD
Enprofylline—ADORA1—GPCR ligand binding—CCL5—metabolic syndrome X	0.00359	0.00359	CbGpPWpGaD
Enprofylline—ADORA2A—GPCR ligand binding—CNR1—metabolic syndrome X	0.00358	0.00358	CbGpPWpGaD
Enprofylline—ADORA2B—GPCR ligand binding—AGT—metabolic syndrome X	0.00353	0.00353	CbGpPWpGaD
Enprofylline—ADORA2B—GPCR downstream signaling—HTR2C—metabolic syndrome X	0.00343	0.00343	CbGpPWpGaD
Enprofylline—ADORA1—Signaling by GPCR—MTNR1B—metabolic syndrome X	0.0034	0.0034	CbGpPWpGaD
Enprofylline—PDE4B—Signaling by GPCR—MTNR1B—metabolic syndrome X	0.00336	0.00336	CbGpPWpGaD
Enprofylline—ADORA2A—Circadian rythm related genes—SERPINE1—metabolic syndrome X	0.00334	0.00334	CbGpPWpGaD
Enprofylline—ADORA2B—GPCR downstream signaling—GHRL—metabolic syndrome X	0.00325	0.00325	CbGpPWpGaD
Enprofylline—ADORA1—Class A/1 (Rhodopsin-like receptors)—CCL2—metabolic syndrome X	0.00325	0.00325	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling by GPCR—HTR2C—metabolic syndrome X	0.00311	0.00311	CbGpPWpGaD
Enprofylline—PDE4A—GPCR downstream signaling—HTR2C—metabolic syndrome X	0.00311	0.00311	CbGpPWpGaD
Enprofylline—ADORA2B—GPCR downstream signaling—CNR1—metabolic syndrome X	0.00308	0.00308	CbGpPWpGaD
Enprofylline—ADORA2A—Class A/1 (Rhodopsin-like receptors)—AGT—metabolic syndrome X	0.00304	0.00304	CbGpPWpGaD
Enprofylline—ADORA1—GPCR ligand binding—AGT—metabolic syndrome X	0.003	0.003	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling by GPCR—GHRL—metabolic syndrome X	0.00295	0.00295	CbGpPWpGaD
Enprofylline—PDE4A—GPCR downstream signaling—GHRL—metabolic syndrome X	0.00295	0.00295	CbGpPWpGaD
Enprofylline—ADORA1—GPCR downstream signaling—HTR2C—metabolic syndrome X	0.00292	0.00292	CbGpPWpGaD
Enprofylline—ADORA2B—GPCR ligand binding—CCL2—metabolic syndrome X	0.00291	0.00291	CbGpPWpGaD
Enprofylline—ADORA2A—GPCR downstream signaling—MTNR1B—metabolic syndrome X	0.00289	0.00289	CbGpPWpGaD
Enprofylline—PDE4B—GPCR downstream signaling—HTR2C—metabolic syndrome X	0.00288	0.00288	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling by NGF—IRS1—metabolic syndrome X	0.00286	0.00286	CbGpPWpGaD
Enprofylline—PDE4A—Signaling by GPCR—HTR2C—metabolic syndrome X	0.00283	0.00283	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling by GPCR—CNR1—metabolic syndrome X	0.0028	0.0028	CbGpPWpGaD
Enprofylline—PDE4A—GPCR downstream signaling—CNR1—metabolic syndrome X	0.0028	0.0028	CbGpPWpGaD
Enprofylline—ADORA2A—GPCR ligand binding—CCL5—metabolic syndrome X	0.00277	0.00277	CbGpPWpGaD
Enprofylline—ADORA1—GPCR downstream signaling—GHRL—metabolic syndrome X	0.00276	0.00276	CbGpPWpGaD
Enprofylline—PDE4B—GPCR downstream signaling—GHRL—metabolic syndrome X	0.00273	0.00273	CbGpPWpGaD
Enprofylline—PDE4A—Signaling by GPCR—GHRL—metabolic syndrome X	0.00268	0.00268	CbGpPWpGaD
Enprofylline—ADORA1—Signaling by GPCR—HTR2C—metabolic syndrome X	0.00265	0.00265	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—HDAC3—metabolic syndrome X	0.00264	0.00264	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling by GPCR—MTNR1B—metabolic syndrome X	0.00262	0.00262	CbGpPWpGaD
Enprofylline—ADORA1—GPCR downstream signaling—CNR1—metabolic syndrome X	0.00262	0.00262	CbGpPWpGaD
Enprofylline—PDE4B—Signaling by GPCR—HTR2C—metabolic syndrome X	0.00262	0.00262	CbGpPWpGaD
Enprofylline—PDE4B—GPCR downstream signaling—CNR1—metabolic syndrome X	0.00259	0.00259	CbGpPWpGaD
Enprofylline—PDE4A—Signaling by GPCR—CNR1—metabolic syndrome X	0.00254	0.00254	CbGpPWpGaD
Enprofylline—ADORA1—Signaling by GPCR—GHRL—metabolic syndrome X	0.00251	0.00251	CbGpPWpGaD
Enprofylline—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CCL2—metabolic syndrome X	0.00251	0.00251	CbGpPWpGaD
Enprofylline—PDE4B—Myometrial Relaxation and Contraction Pathways—IL6—metabolic syndrome X	0.0025	0.0025	CbGpPWpGaD
Enprofylline—PDE4B—Signaling by GPCR—GHRL—metabolic syndrome X	0.00248	0.00248	CbGpPWpGaD
Enprofylline—ADORA1—GPCR ligand binding—CCL2—metabolic syndrome X	0.00247	0.00247	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—HDAC3—metabolic syndrome X	0.0024	0.0024	CbGpPWpGaD
Enprofylline—ADORA2B—GPCR downstream signaling—CCL5—metabolic syndrome X	0.00239	0.00239	CbGpPWpGaD
Enprofylline—ADORA1—Signaling by GPCR—CNR1—metabolic syndrome X	0.00238	0.00238	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—MTNR1B—metabolic syndrome X	0.00236	0.00236	CbGpPWpGaD
Enprofylline—PDE4B—Signaling by GPCR—CNR1—metabolic syndrome X	0.00235	0.00235	CbGpPWpGaD
Enprofylline—ADORA2A—GPCR ligand binding—AGT—metabolic syndrome X	0.00232	0.00232	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—RBP4—metabolic syndrome X	0.0023	0.0023	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—TRIB3—metabolic syndrome X	0.0023	0.0023	CbGpPWpGaD
Enprofylline—ADORA2A—GPCR downstream signaling—HTR2C—metabolic syndrome X	0.00225	0.00225	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—HDAC3—metabolic syndrome X	0.00225	0.00225	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—HDAC3—metabolic syndrome X	0.00222	0.00222	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling by GPCR—CCL5—metabolic syndrome X	0.00217	0.00217	CbGpPWpGaD
Enprofylline—PDE4A—GPCR downstream signaling—CCL5—metabolic syndrome X	0.00217	0.00217	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling by GPCR—PLA2G4A—metabolic syndrome X	0.00216	0.00216	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—MTNR1B—metabolic syndrome X	0.00214	0.00214	CbGpPWpGaD
Enprofylline—ADORA2A—GPCR downstream signaling—GHRL—metabolic syndrome X	0.00213	0.00213	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—TRIB3—metabolic syndrome X	0.00209	0.00209	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—RBP4—metabolic syndrome X	0.00209	0.00209	CbGpPWpGaD
Enprofylline—ADORA1—Circadian rythm related genes—IL6—metabolic syndrome X	0.00206	0.00206	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling by GPCR—HTR2C—metabolic syndrome X	0.00204	0.00204	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—APOC3—metabolic syndrome X	0.00204	0.00204	CbGpPWpGaD
Enprofylline—ADORA1—GPCR downstream signaling—CCL5—metabolic syndrome X	0.00203	0.00203	CbGpPWpGaD
Enprofylline—ADORA2A—GPCR downstream signaling—CNR1—metabolic syndrome X	0.00202	0.00202	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—MTNR1B—metabolic syndrome X	0.00201	0.00201	CbGpPWpGaD
Enprofylline—PDE4B—GPCR downstream signaling—CCL5—metabolic syndrome X	0.002	0.002	CbGpPWpGaD
Enprofylline—ADORA2B—GPCR downstream signaling—AGT—metabolic syndrome X	0.002	0.002	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—MTNR1B—metabolic syndrome X	0.00198	0.00198	CbGpPWpGaD
Enprofylline—PDE4A—Signaling by GPCR—CCL5—metabolic syndrome X	0.00197	0.00197	CbGpPWpGaD
Enprofylline—PDE4A—Signaling by GPCR—PLA2G4A—metabolic syndrome X	0.00196	0.00196	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—TRIB3—metabolic syndrome X	0.00196	0.00196	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—RBP4—metabolic syndrome X	0.00196	0.00196	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling by GPCR—GHRL—metabolic syndrome X	0.00194	0.00194	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—RBP4—metabolic syndrome X	0.00193	0.00193	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—TRIB3—metabolic syndrome X	0.00193	0.00193	CbGpPWpGaD
Enprofylline—ADORA2A—GPCR ligand binding—CCL2—metabolic syndrome X	0.00191	0.00191	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—APOC3—metabolic syndrome X	0.00185	0.00185	CbGpPWpGaD
Enprofylline—ADORA1—Signaling by GPCR—CCL5—metabolic syndrome X	0.00184	0.00184	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—HTR2C—metabolic syndrome X	0.00184	0.00184	CbGpPWpGaD
Enprofylline—ADORA1—Signaling by GPCR—PLA2G4A—metabolic syndrome X	0.00184	0.00184	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling by GPCR—CNR1—metabolic syndrome X	0.00184	0.00184	CbGpPWpGaD
Enprofylline—PDE4B—Signaling by GPCR—CCL5—metabolic syndrome X	0.00182	0.00182	CbGpPWpGaD
Enprofylline—PDE4B—Signaling by GPCR—PLA2G4A—metabolic syndrome X	0.00181	0.00181	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling by GPCR—AGT—metabolic syndrome X	0.00181	0.00181	CbGpPWpGaD
Enprofylline—PDE4A—GPCR downstream signaling—AGT—metabolic syndrome X	0.00181	0.00181	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—CYBA—metabolic syndrome X	0.00178	0.00178	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—GHRL—metabolic syndrome X	0.00174	0.00174	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—HDAC3—metabolic syndrome X	0.00173	0.00173	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—APOC3—metabolic syndrome X	0.00173	0.00173	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—APOC3—metabolic syndrome X	0.00171	0.00171	CbGpPWpGaD
Enprofylline—ADORA1—GPCR downstream signaling—AGT—metabolic syndrome X	0.0017	0.0017	CbGpPWpGaD
Enprofylline—PDE4B—GPCR downstream signaling—AGT—metabolic syndrome X	0.00168	0.00168	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—HTR2C—metabolic syndrome X	0.00167	0.00167	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—CNR1—metabolic syndrome X	0.00165	0.00165	CbGpPWpGaD
Enprofylline—PDE4A—Signaling by GPCR—AGT—metabolic syndrome X	0.00165	0.00165	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—CYBA—metabolic syndrome X	0.00162	0.00162	CbGpPWpGaD
Enprofylline—ADORA2A—Circadian rythm related genes—IL6—metabolic syndrome X	0.00159	0.00159	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—GHRL—metabolic syndrome X	0.00158	0.00158	CbGpPWpGaD
Enprofylline—ADORA2A—GPCR downstream signaling—CCL5—metabolic syndrome X	0.00157	0.00157	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—HTR2C—metabolic syndrome X	0.00156	0.00156	CbGpPWpGaD
Enprofylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—IL6—metabolic syndrome X	0.00156	0.00156	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—MTNR1B—metabolic syndrome X	0.00155	0.00155	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—HTR2C—metabolic syndrome X	0.00155	0.00155	CbGpPWpGaD
Enprofylline—ADORA1—Signaling by GPCR—AGT—metabolic syndrome X	0.00154	0.00154	CbGpPWpGaD
Enprofylline—PDE4B—Signaling by GPCR—AGT—metabolic syndrome X	0.00152	0.00152	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—CYBA—metabolic syndrome X	0.00151	0.00151	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—RBP4—metabolic syndrome X	0.00151	0.00151	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—TRIB3—metabolic syndrome X	0.00151	0.00151	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—CNR1—metabolic syndrome X	0.0015	0.0015	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—CYBA—metabolic syndrome X	0.0015	0.0015	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling by GPCR—CCL2—metabolic syndrome X	0.00149	0.00149	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—GHRL—metabolic syndrome X	0.00148	0.00148	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—GHRL—metabolic syndrome X	0.00147	0.00147	CbGpPWpGaD
Enprofylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—AKT1—metabolic syndrome X	0.00144	0.00144	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling by GPCR—CCL5—metabolic syndrome X	0.00142	0.00142	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling by GPCR—PLA2G4A—metabolic syndrome X	0.00142	0.00142	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—CNR1—metabolic syndrome X	0.0014	0.0014	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—CNR1—metabolic syndrome X	0.00139	0.00139	CbGpPWpGaD
Enprofylline—PDE4A—Signaling by GPCR—CCL2—metabolic syndrome X	0.00136	0.00136	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—IGF2—metabolic syndrome X	0.00135	0.00135	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—APOC3—metabolic syndrome X	0.00134	0.00134	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—APOB—metabolic syndrome X	0.00131	0.00131	CbGpPWpGaD
Enprofylline—ADORA2A—GPCR downstream signaling—AGT—metabolic syndrome X	0.00131	0.00131	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—CCL5—metabolic syndrome X	0.00128	0.00128	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—PLA2G4A—metabolic syndrome X	0.00127	0.00127	CbGpPWpGaD
Enprofylline—ADORA1—Signaling by GPCR—CCL2—metabolic syndrome X	0.00127	0.00127	CbGpPWpGaD
Enprofylline—PDE4B—Signaling by GPCR—CCL2—metabolic syndrome X	0.00125	0.00125	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—LPL—metabolic syndrome X	0.00125	0.00125	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—IGF2—metabolic syndrome X	0.00123	0.00123	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—HTR2C—metabolic syndrome X	0.00121	0.00121	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling by NGF—IL6—metabolic syndrome X	0.0012	0.0012	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—APOB—metabolic syndrome X	0.00119	0.00119	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling by GPCR—AGT—metabolic syndrome X	0.00119	0.00119	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—CYBA—metabolic syndrome X	0.00117	0.00117	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—CCL5—metabolic syndrome X	0.00116	0.00116	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—PLA2G4A—metabolic syndrome X	0.00116	0.00116	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—IGF2—metabolic syndrome X	0.00115	0.00115	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—GHRL—metabolic syndrome X	0.00114	0.00114	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—LPL—metabolic syndrome X	0.00114	0.00114	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—IGF2—metabolic syndrome X	0.00113	0.00113	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—APOB—metabolic syndrome X	0.00111	0.00111	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling by NGF—AKT1—metabolic syndrome X	0.0011	0.0011	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—APOB—metabolic syndrome X	0.0011	0.0011	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—CCL5—metabolic syndrome X	0.00109	0.00109	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—PLA2G4A—metabolic syndrome X	0.00108	0.00108	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—CNR1—metabolic syndrome X	0.00108	0.00108	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—CCL5—metabolic syndrome X	0.00108	0.00108	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—PLA2G4A—metabolic syndrome X	0.00107	0.00107	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—AGT—metabolic syndrome X	0.00107	0.00107	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—LPL—metabolic syndrome X	0.00106	0.00106	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—LPL—metabolic syndrome X	0.00105	0.00105	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—LEP—metabolic syndrome X	0.00105	0.00105	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—APOE—metabolic syndrome X	0.00105	0.00105	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—APOA1—metabolic syndrome X	0.00104	0.00104	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling by GPCR—CCL2—metabolic syndrome X	0.00098	0.00098	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—AGT—metabolic syndrome X	0.000972	0.000972	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—LEP—metabolic syndrome X	0.000952	0.000952	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—APOE—metabolic syndrome X	0.000952	0.000952	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—APOA1—metabolic syndrome X	0.000942	0.000942	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—IRS1—metabolic syndrome X	0.000936	0.000936	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—AGT—metabolic syndrome X	0.00091	0.00091	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—AGT—metabolic syndrome X	0.000899	0.000899	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—INS—metabolic syndrome X	0.000896	0.000896	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—LEP—metabolic syndrome X	0.000892	0.000892	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—APOE—metabolic syndrome X	0.000892	0.000892	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—IGF2—metabolic syndrome X	0.000886	0.000886	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—CCL2—metabolic syndrome X	0.000882	0.000882	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—APOA1—metabolic syndrome X	0.000882	0.000882	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—APOE—metabolic syndrome X	0.000881	0.000881	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—LEP—metabolic syndrome X	0.000881	0.000881	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—APOA1—metabolic syndrome X	0.000871	0.000871	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—IGF1—metabolic syndrome X	0.000867	0.000867	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—APOB—metabolic syndrome X	0.00086	0.00086	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—IRS1—metabolic syndrome X	0.00085	0.00085	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—CCL5—metabolic syndrome X	0.00084	0.00084	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—PLA2G4A—metabolic syndrome X	0.000837	0.000837	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—SERPINE1—metabolic syndrome X	0.000823	0.000823	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—LPL—metabolic syndrome X	0.000822	0.000822	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—INS—metabolic syndrome X	0.000814	0.000814	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—CCL2—metabolic syndrome X	0.000801	0.000801	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—IRS1—metabolic syndrome X	0.000796	0.000796	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—IGF1—metabolic syndrome X	0.000787	0.000787	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—IRS1—metabolic syndrome X	0.000786	0.000786	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—NOS3—metabolic syndrome X	0.000786	0.000786	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—INS—metabolic syndrome X	0.000762	0.000762	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—INS—metabolic syndrome X	0.000753	0.000753	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—CCL2—metabolic syndrome X	0.00075	0.00075	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—SERPINE1—metabolic syndrome X	0.000747	0.000747	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—CCL2—metabolic syndrome X	0.000741	0.000741	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—IGF1—metabolic syndrome X	0.000737	0.000737	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—IGF1—metabolic syndrome X	0.000728	0.000728	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—NOS3—metabolic syndrome X	0.000714	0.000714	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—AGT—metabolic syndrome X	0.000703	0.000703	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—SERPINE1—metabolic syndrome X	0.0007	0.0007	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—SERPINE1—metabolic syndrome X	0.000692	0.000692	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—LEP—metabolic syndrome X	0.000689	0.000689	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—APOE—metabolic syndrome X	0.000689	0.000689	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—APOA1—metabolic syndrome X	0.000681	0.000681	CbGpPWpGaD
Enprofylline—ADORA2B—GPCR downstream signaling—AKT1—metabolic syndrome X	0.000673	0.000673	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—NOS3—metabolic syndrome X	0.000668	0.000668	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling by GPCR—IL6—metabolic syndrome X	0.000663	0.000663	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—NOS3—metabolic syndrome X	0.00066	0.00066	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—IRS1—metabolic syndrome X	0.000614	0.000614	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling by GPCR—AKT1—metabolic syndrome X	0.000612	0.000612	CbGpPWpGaD
Enprofylline—PDE4A—GPCR downstream signaling—AKT1—metabolic syndrome X	0.000611	0.000611	CbGpPWpGaD
Enprofylline—PDE4A—Signaling by GPCR—IL6—metabolic syndrome X	0.000602	0.000602	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—INS—metabolic syndrome X	0.000588	0.000588	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—CCL2—metabolic syndrome X	0.000579	0.000579	CbGpPWpGaD
Enprofylline—ADORA1—GPCR downstream signaling—AKT1—metabolic syndrome X	0.000573	0.000573	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—IGF1—metabolic syndrome X	0.000569	0.000569	CbGpPWpGaD
Enprofylline—PDE4B—GPCR downstream signaling—AKT1—metabolic syndrome X	0.000566	0.000566	CbGpPWpGaD
Enprofylline—ADORA1—Signaling by GPCR—IL6—metabolic syndrome X	0.000564	0.000564	CbGpPWpGaD
Enprofylline—PDE4B—Signaling by GPCR—IL6—metabolic syndrome X	0.000557	0.000557	CbGpPWpGaD
Enprofylline—PDE4A—Signaling by GPCR—AKT1—metabolic syndrome X	0.000555	0.000555	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—SERPINE1—metabolic syndrome X	0.00054	0.00054	CbGpPWpGaD
Enprofylline—ADORA1—Signaling by GPCR—AKT1—metabolic syndrome X	0.00052	0.00052	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—TGFB1—metabolic syndrome X	0.00052	0.00052	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—NOS3—metabolic syndrome X	0.000516	0.000516	CbGpPWpGaD
Enprofylline—PDE4B—Signaling by GPCR—AKT1—metabolic syndrome X	0.000514	0.000514	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—TGFB1—metabolic syndrome X	0.000472	0.000472	CbGpPWpGaD
Enprofylline—ADORA2A—GPCR downstream signaling—AKT1—metabolic syndrome X	0.000442	0.000442	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—TGFB1—metabolic syndrome X	0.000442	0.000442	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—TGFB1—metabolic syndrome X	0.000437	0.000437	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling by GPCR—IL6—metabolic syndrome X	0.000435	0.000435	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling by GPCR—AKT1—metabolic syndrome X	0.000401	0.000401	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—IL6—metabolic syndrome X	0.000392	0.000392	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—AKT1—metabolic syndrome X	0.000361	0.000361	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—IL6—metabolic syndrome X	0.000356	0.000356	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—TGFB1—metabolic syndrome X	0.000341	0.000341	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—IL6—metabolic syndrome X	0.000333	0.000333	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—IL6—metabolic syndrome X	0.000329	0.000329	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—AKT1—metabolic syndrome X	0.000328	0.000328	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—AKT1—metabolic syndrome X	0.000307	0.000307	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—AKT1—metabolic syndrome X	0.000304	0.000304	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—IL6—metabolic syndrome X	0.000257	0.000257	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—AKT1—metabolic syndrome X	0.000237	0.000237	CbGpPWpGaD
